Literature DB >> 20545837

Obstructive sleep apnoea and 24-h blood pressure in patients with resistant hypertension.

Patricia Lloberes1, Lourdes Lozano, Gabriel Sampol, Odile Romero, María J Jurado, José Ríos, María D Untoria, José L Tovar.   

Abstract

Obstructive sleep apnoea (OSA) is common in patients with resistant hypertension, but understanding of the pathogenic mechanisms linking both conditions is limited. This study assessed the prevalence of OSA and the relationships between OSA and 24-h blood pressure (BP) in 62 consecutive patients with resistant hypertension, defined as clinic BP values ≥ 140/90 despite the prescription of at least three drugs at adequate doses, including a diuretic. In order to exclude a 'white coat effect', only patients with ambulatory 24-h BP values ≥ 125/80 were recruited. Patients underwent polysomnography, 24-h ambulatory BP monitoring and completed the Epworth sleepiness scale (ESS). OSA was defined as an apnoea-hypopnoea index (AHI) ≥ 5 and excessive daytime sleepiness (EDS) by an ESS ≥ 10. A multiple linear regression analysis was used to assess the association of anthropometric data, OSA severity measures and ESS with 24-h systolic and diastolic BP. Mean 24-h BP values were 139.14/80.98 mmHg. Ninety per cent of patients had an AHI ≥ 5 and 70% had an AHI ≥ 30. Only the ESS was associated with 24-h diastolic BP [slope 0.775, 95% confidence interval (CI) 0.120-1.390, P < 0.02); age was associated negatively with 24-h diastolic BP (slope -0.64, 95% CI -0.874 to -0.411, P < 0.001). Compared with those without EDS, patients with EDS showed a significantly higher frequency of diastolic non-dipping pattern (69.2% versus 34.7%, P < 0.032). Our results demonstrate a high prevalence of severe OSA in patients with resistant hypertension and suggest that EDS could be a marker of a pathogenetic mechanism linking OSA and hypertension.
© 2010 European Sleep Research Society.

Entities:  

Mesh:

Year:  2010        PMID: 20545837     DOI: 10.1111/j.1365-2869.2010.00839.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  15 in total

Review 1.  Supine fluid redistribution: should we consider this as an important risk factor for obstructive sleep apnea?

Authors:  Aibek E Mirrakhimov
Journal:  Sleep Breath       Date:  2012-08-08       Impact factor: 2.816

Review 2.  Effect of renal sympathetic denervation on apnea-hypopnea index in patients with obstructive sleep apnea: a systematic review and meta-analysis.

Authors:  Ghanshyam Palamaner Subash Shantha; Samir Bipin Pancholy
Journal:  Sleep Breath       Date:  2014-05-17       Impact factor: 2.816

3.  Obstructive sleep apnea and diurnal nondipping hemodynamic indices in patients at increased cardiovascular risk.

Authors:  Fadi Seif; Sanjay R Patel; Harneet K Walia; Michael Rueschman; Deepak L Bhatt; Roger S Blumenthal; Stuart F Quan; Daniel J Gottlieb; Eldrin F Lewis; Susheel P Patil; Naresh M Punjabi; Denise C Babineau; Susan Redline; Reena Mehra
Journal:  J Hypertens       Date:  2014-02       Impact factor: 4.844

4.  Clinical characteristics of two groups commonly referred to an Irish hypertension service-patients with resistant hypertension and young adults with hypertension.

Authors:  Cormac Kennedy; Osama Ali; Richard Farnan; John Stinson; Ahmed Gabr; Mary Hall; Patricia O'Connor; Martina Hennessy; Michael Barry
Journal:  Ir J Med Sci       Date:  2022-01-09       Impact factor: 1.568

5.  The impact of sleep duration in obstructive sleep apnea patients.

Authors:  Thaís T Risso; Dalva Poyares; Camila F Rizzi; Cristiane Pulz; Christian Guilleminault; Sergio Tufik; Angelo A V de Paola; Fátima Cintra
Journal:  Sleep Breath       Date:  2012-10-26       Impact factor: 2.816

Review 6.  Obstructive sleep apnea, hypertension and cardiovascular diseases.

Authors:  C Gonzaga; A Bertolami; M Bertolami; C Amodeo; D Calhoun
Journal:  J Hum Hypertens       Date:  2015-03-12       Impact factor: 3.012

7.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

Review 8.  Resistant hypertension in diabetes mellitus.

Authors:  George Bayliss; Larry A Weinrauch; John A D'Elia
Journal:  Curr Diab Rep       Date:  2014-08       Impact factor: 4.810

9.  Common secondary causes of resistant hypertension and rational for treatment.

Authors:  Charles Faselis; Michael Doumas; Vasilios Papademetriou
Journal:  Int J Hypertens       Date:  2011-03-02       Impact factor: 2.420

Review 10.  Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!

Authors:  Giuseppe Maiolino; Matteo Azzolini; Gian Paolo Rossi
Journal:  Front Cardiovasc Med       Date:  2015-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.